Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Acromegaly Market Poised for Significant Expansion During the Forecast Period (2026-2036) as New Treatment Options Emerge | DelveInsight
-
Black Stone Minerals, L.P. Announces Fourth Quarter and Full Year 2025 Results; Provides Guidance for 2026
-
Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium
-
HelloNation Explores How to Choose an Orthodontist Featuring Expert Orthodontist Dr. Michelle Mathieson, DMD, MSD
-
Creatd Completes 1:20 Reverse Stock Split as Part of Uplisting Strategy
-
Alex Wilcox Continues to Shape Customer-Focused Air Travel Through Leadership at JSX
-
Haivision to Announce First Quarter Fiscal 2026 Financial Results on March 12, 2026
-
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
-
Alm. Brand A/S - Rasmus Werner Nielsen has chosen to step down as CEO of Alm. Brand A/S – Deputy CEO Andreas Ruben Madsen appointed new CEO
-
AV Announces Retirement of Chief Financial Officer Kevin McDonnell
-
PlusAI to Participate in Upcoming Investor Conferences
-
Central Securities Corporation Releases Annual Report to Stockholders for the Year Ended December 31, 2025
-
GERDAU S.A. - CONSOLIDATED INFORMATION
-
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be P
-
T2 Metals Invites Shareholders and Investment Community to visit them at Booth 2941 at PDAC 2026 in Toronto, March 1-4
-
Dillard’s, Inc. to Report Fourth Quarter and Fiscal Year Results
-
Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in January
-
CORRECTING and REPLACING Arenales Summit Becomes Home to Puerto Rico's First Hockey League Thanks to Landmark Renovation Funded by Risk’s Rewards LLC
-
22nd Century Group Reports Continued Early Sales Momentum for VLN® Cigarette Products
-
Ovintiv Reports Fourth Quarter and Year-End 2025 Financial and Operating Results
-
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
-
Clear Street Expands into Asia-Pacific Region With Acquisition of Boom Securities
-
Ero Announces Inaugural PEA for Furnas, Outlines Low Capital Intensity Project with a 24-Year Initial Mine Life
-
Navigating Tariffs and Uncertainty: How Canada's Real Estate Leaders Are Staying the Course
-
Dime Community Bank to Rebrand as Dime Commercial Bank Company to Transfer Listing of Its Securities to New York Stock Exchange
-
HelloNation Examines The Science Behind Natural Topical Pain Relief Featuring Wellness Expert Josh Hansen
-
Microplastics Discovered in Prostate Tumors
-
Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
-
NorthStar Gaming Provides Update on Strategic Priorities for 2026
-
Alpha Expands Anagulu Porphyry Mineralisation with Drill Intercept of 120 metres Grading 0.30% Copper and 0.47 g/t Gold
-
Legend Power Systems Schedules Q1 2026 Financial Results Release and Webinar for March 2, 2026
-
CEMATRIX Announces $5.2 Million in New Contract Awards
-
KBRA Comments on Blue Owl Capital Corporation II's Asset Sales
-
Palamina Corp Invites Shareholders and Investment Community to visit them at Booth 2723 at PDAC 2026 in Toronto, March 1-4
-
EFT Appoints Dr. Helge Sachs as Chief Development Officer to Advance SAF Production Projects in Europe and the UK
-
Zillow to host AI Summit for Investors: Leading the Next Era of Real Estate
-
Lady Luck HQ and Friends: Birthday Triathlon Weekend Big Success at Seminole Hard Rock Hotel & Casino Tampa
-
SHARC Energy Closes First Tranche of Debenture
-
Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
-
Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malf
-
Empire State Realty Trust Achieves WELL Health-Safety Leadership Award for Second Consecutive Year and Healthy Building Catalyst Award
-
Better and Framework Ventures Announce Strategic Partnership to Enable Deployment of $500MM into Better via Sky’s Stablecoin Ecosystem
-
Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer
-
Flatiron Health Attends the 2026 American Society of Genitourinary Cancers Symposium to Answer Oncology's Most Critical Questions
-
Klaviyo Executives to Participate in Morgan Stanley Technology, Media & Telecom Conference
-
AMC Networks Announces Any and All Exchange Offer and Consent Solicitation for its 10.25% Senior Secured Notes due 2029
-
Announces Its Strategic Partnership with Guizhou Zhongke Molecular Biotechnology Co., Ltd
-
Jericho Energy Ventures (TSXV: JEV) Closes USD$1.5 Million Strategic Investment from Comstock Holding Companies (Nasdaq: CHCI)
-
AMC Networks Announces Effectiveness of Amendments to its 10.50% Senior Secured Notes due 2032 and Extension of Consent Solicitation
-
Clear Street Announces Voluntary SEC Deregistration
